Literature DB >> 8055364

The effect of endogenous parathyroid hormone, exogenous calcitonin, and dibutyryl cyclic AMP on urinary excretion of N-acetyl-beta-D-glucosaminidase.

K Mizunashi1, Y Furukawa, K Yoshinaga.   

Abstract

Urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) transiently increases after PTH(1-34) infusion in idiopathic hypoparathyroidism (IHP) but this response is impaired in pseudohypoparathyroidism (PHP) type I. We investigated the effects of endogenous PTH, exogenous calcitonin (CT), and dibutyryl cAMP (DBcAMP) on urinary excretion of NAG. Urinary NAG excretion in 14 patients with primary hyperparathyroidism (1 degree HPT) was more than in normal subjects (P < 0.001) and decreased after parathyroidectomy (P < 0.01). Urinary NAG excretion increased after the infusion of 1.5 MRC/kg of eel CT in eight normal subjects (P < 0.001), two patients with IHP, and a patient with PHP type Ib but not in a patient with PHP type Ia. The increases of urinary NAG excretion by CT and by PTH(1-34) were positively correlated with the increases of urinary cAMP excretion (r = 0.752; P < 0.001 and r = 0.534; P < 0.002, respectively). Urinary NAG excretion increased after DB-cAMP infusion in five normal subjects (P < 0.01), two patients with IHP, and two with PHP type I. The increase of urinary NAG by 6.0 mg/kg of DBcAMP was more than by 2.5 mg/kg of DBcAMP in normal subjects (P < 0.01). The increase of urinary NAG by 2.5 mg/kg of DBcAMP in PHP type I was comparable with that by 6.0 mg/kg in normal subjects, suggesting a hyperresponsiveness to DBcAMP in PHP type I. Urinary excretion of NAG is a useful indicator of renal tubular responsiveness to PTH and CT. Cyclic AMP-dependent mechanism is probably involved in PTH and CT-induced increase in urinary excretion of NAG.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8055364     DOI: 10.1007/bf00301676

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  33 in total

1.  The excretion of N-acetyl-beta-glucosaminidase and beta-galactosidase by patients with renal disease.

Authors:  N Dance; R G Price; W R Cattell; J Lansdell; B Richards
Journal:  Clin Chim Acta       Date:  1970-01       Impact factor: 3.786

Review 2.  PTH, calcitonin, cyclic nucleotides and the kidney.

Authors:  Z S Agus; A Wasserstein; S Goldfarb
Journal:  Annu Rev Physiol       Date:  1981       Impact factor: 19.318

3.  Distribution of N-acetyl-beta-D-glucosaminidase isoenzymes along the rabbit nephron.

Authors:  R Bourbouze; F C Baumann; J P Bonvalet; N Farman
Journal:  Kidney Int       Date:  1984-04       Impact factor: 10.612

4.  Adenylate cyclase responsiveness to hormones in various portions of the human nephron.

Authors:  D Chabardès; M Gagnan-Brunette; M Imbert-Teboul; O Gontcharevskaia; M Montégut; A Clique; F Morel
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

5.  Effects of parathyroid hormone on urinary excretion of N-acetyl-beta-D-glucosaminidase in idiopathic hypoparathyroidism and pseudohypoparathyroidism.

Authors:  K Mizunashi; Y Furukawa; K Taguchi; M Kuwahara; R Miura; S Yumita; K Yoshinaga
Journal:  Calcif Tissue Int       Date:  1989-12       Impact factor: 4.333

6.  Effects of active vitamin D3 and parathyroid hormone on the serum osteocalcin in idiopathic hypoparathyroidism and pseudohypoparathyroidism.

Authors:  K Mizunashi; Y Furukawa; R Miura; S Yumita; H E Sohn; K Yoshinaga
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

7.  Human PTH(1-34) infusion test in differential diagnosis of various types of hypoparathyroidism: an attempt to establish a standard clinical test.

Authors:  M Yamamoto; Y Furukawa; Y Konagaya; H E Sohn; A Tomita; T Fujita; E Ogata
Journal:  Bone Miner       Date:  1989-05

8.  Effect of dibutyryl adenosine 3',5'-monophosphate administration on plasma concentrations of 1,25-dihydroxyvitamin D in pseudohypoparathyroidism type I.

Authors:  K Yamaoka; Y Seino; M Ishida; T Ishii; T Shimotsuji; Y Tanaka; H Kurose; S Matsuda; K Satomura; H Yabuuchi
Journal:  J Clin Endocrinol Metab       Date:  1981-11       Impact factor: 5.958

Review 9.  Parathyroid hormone receptors in control of proximal tubule function.

Authors:  R Muff; J A Fischer; J Biber; H Murer
Journal:  Annu Rev Physiol       Date:  1992       Impact factor: 19.318

10.  Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium.

Authors:  A B Abou-Samra; H Jüppner; T Force; M W Freeman; X F Kong; E Schipani; P Urena; J Richards; J V Bonventre; J T Potts
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

View more
  2 in total

1.  Dose and chemical modification considerations for continuous cyclic AMP analog delivery to the injured CNS.

Authors:  Karim Fouad; Mousumi Ghosh; Romana Vavrek; Arthur D Tse; Damien D Pearse
Journal:  J Neurotrauma       Date:  2009-05       Impact factor: 5.269

2.  Resetting of parathyroid hormone secretion after vitamin D3 treatment in hypoparathyroidism and after parathyroid adenectomy in primary hyperparathyroidism.

Authors:  K Mizunashi; Y Furukawa; K Abe; K Takaya; K Yoshinaga
Journal:  Calcif Tissue Int       Date:  1995-07       Impact factor: 4.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.